Analysts have been eager to weigh in on the Healthcare sector with new ratings on Medtronic (MDT – Research Report), Globus Medical (GMED – Research Report) and Zai Lab (ZLAB – Research Report).
Medtronic (MDT)
Bank of America Securities analyst Travis Steed reiterated a Buy rating on Medtronic today and set a price target of $100.00. The company’s shares closed last Tuesday at $85.85.
According to TipRanks.com, Steed is a 5-star analyst with an average return of
Currently, the analyst consensus on Medtronic is a Moderate Buy with an average price target of $92.64, implying a 6.5% upside from current levels. In a report released yesterday, Evercore ISI also maintained a Buy rating on the stock with a $100.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
Globus Medical (GMED)
Bank of America Securities analyst Craig Bijou reiterated a Sell rating on Globus Medical today and set a price target of $55.00. The company’s shares closed last Tuesday at $54.16.
According to TipRanks.com, Bijou is a 3-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Globus Medical with a $66.00 average price target.
Zai Lab (ZLAB)
Bank of America Securities analyst David Li reiterated a Buy rating on Zai Lab today and set a price target of $31.00. The company’s shares closed last Tuesday at $19.24, close to its 52-week low of $17.69.
According to TipRanks.com, Li is ranked #8498 out of 8726 analysts.
Currently, the analyst consensus on Zai Lab is a Strong Buy with an average price target of $61.50, a 207.5% upside from current levels. In a report issued on February 13, Cantor Fitzgerald also maintained a Buy rating on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on MDT:
